WFA
ANAB icon

Wipfli Financial Advisors’s AnaptysBio ANAB Stock Holding History

Wipfli Financial Advisors’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$3K Buy
+133
New +$3.12K ﹤0.01% 2185

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Wipfli Financial Advisors's ANAB Position: Q3 2022 in Review

Wipfli Financial Advisors opened a new position in AnaptysBio (ANAB) in Q3 2022: 133 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #2185 among its holdings.

114 funds tracked by Wall St. Rank hold ANAB as of Q3 2022.

  • Wipfli Financial Advisors held 133 shares of AnaptysBio worth $3K as of Q3 2022.
  • AnaptysBio was a new Wipfli Financial Advisors position in Q3 2022.
  • AnaptysBio made up ﹤0.01% of Wipfli Financial Advisors's portfolio in Q3 2022, its #2185 holding.
  • 114 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2022.

Based on Wipfli Financial Advisors's 13F filing for Q3 2022, filed 26 Oct 2022.